INS and type 1 diabetes mellitus: Both oral and nasal insulin have been evaluated in T1D prevention trials [5], [6], while nasal insulin, DNA encoding proinsulin, proinsulin peptide, and insulin B-chain formulated in adjuvant have been administered in new-onset and established T1D [7]–[10].